ATS seeks US trial for faster heart valve replacement technology
This article was originally published in Clinica
ATS Medical has submitted to the FDA an investigational device exemption for permission to begin US clinical trials of a tissue valve product that it claims can be implanted more quickly and easily than current valve replacements.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.